Silva Paul M
SEC Form 4 insider trading activity
Silva Paul M has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.
On the most recent filing, Silva Paul M is listed as Director at Rapport Therapeutics, Inc. Inside the rolling window, Silva Paul M reported 1 open-market purchase totaling $100K in RAPP and no open-market sales.
Companies traded
Other insiders at RAPP
Insider Buying
$100K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Silva Paul M made?
Silva Paul M has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Silva Paul M trade?
Silva Paul M has filed SEC Form 4 disclosures for 1 company, including RAPP.
When was Silva Paul M's most recent SEC Form 4 filing?
Silva Paul M's most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.
What is Silva Paul M's total buy and sell value in the current window?
Inside the rolling retention window, Silva Paul M bought $100K and sold $0 based on SEC Form 4 filings.
What was Silva Paul M's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,680 RAPP shares on 2026-10-22, worth $100K, per SEC Form 4 filings.